Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +48.68%
#3 DOVU DOVU +48.00%
#4 Velvet Velvet +44.04%
#5 Black Phoenix Black Phoenix +34.47%
#6 Perle Perle +19.03%
#7 Cross Cross +18.07%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.92%
#9 τemplar τemplar +16.86%
#10 Cysic Cysic +15.93%
Coin of the day
Glidr Glidr
設定
言語
日本
通貨
USD
テーマ
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVXA
株式のランク #38531
Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc... Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc operates as a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market innovative therapies for various female sexual dysfunctions. Its primary drug candidate, BP-101, is being developed as a medical treatment for premenopausal women diagnosed with hypoactive sexual desire disorder. This compound is presently in Phase II clinical investigation in Australia and New Zealand, and has progressed to Phase III clinical trials within Russia. Beyond its core pharmaceutical work, the company also participates in mineral exploration and offers supplementary support services. The organization, originally incorporated as Ovoca Gold plc, rebranded to Ovoca Bio plc in July 2018.
株価
$0.01142111
最終同期: 2025-03-21
時価総額
$930.66K
変化（1日）
0.18%
変化（1年）
0.00%
国
IE
取引 Ovoca Bio plc (OVXA)

カテゴリー

Healthcare
Ovoca Bio plc（OVXA）のEPS
2026 時点のEPS TTM: 0
Ovoca Bio plcの最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Ovoca Bio plcのEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE